Understanding the performance of metals is related to its structure at many different length scales, from the atomic level all the way up to the macro-sized object. Being able to knit these length scales together for their chemistry, microstructure and defect structure is critical to deisgning new parts for high performance applications, sch as power […]

The Ontario Association of Young Parent Agencies (OAYPA), via Abonia Centre, requested a study to examine 1) available treatment programs available to pregnant and parenting transition aged youth (TAY) and their children, in Ontario; 2) demographics of TAY who access these programs; 3) literature on promising practices for treatment programs for TAY. This study will […]

Our project focuses on developing a bioprinting technology for treating severe burns. We aim to reduce scarring and enhance skin regeneration, which can significantly improve the lives of burn victims. This technology has the potential to make a big difference in the medical field, but it’s a challenging journey, especially due to the strict regulations […]

Urinary tract infections (UTIs) are one of the most common bacterial infections globally, affecting millions of people each year. The inappropriate use of antibiotics for UTIs is a significant driver of antibiotic resistance, posing a grave threat to public health. Complicated UTIs, characterized by treatment failure, recurrent infections, and increased mortality, disproportionately affect vulnerable populations, […]

We appear to be at the beginning of a revolution in the development of new technologies based on quantum science. Over the past several years, Canada has become a world leader in quantum information research and in the development of these emerging quantum technologies. Quantum computers that are based on optical architectures include some of […]

In collaboration with CAE, the project’s primary goal is to identify an appropriate material to isolate a battery pack in a hybrid electric aircraft. The chosen material must be as light as possible, while meeting appropriate safety standards. This battery module will be integrated into an aircraft for testing by the industry partner. With a […]

In this project, the team will build a strong business foundation for a startup vehicle ‘Neuropeutics Inc’ to conduct further R&D and commercialize a new effective treatment for neurodegenerative diseases, namely ALS and FTD. That is, the team will develop a sustainable business model, a financial budget, a funds raising plan and marketing material. The […]

Surgery places significant stress on the body, much like running a marathon does. However, while marathon runners rigorously train before their race, most Canadians are not preparing for surgeries. Not only does a wealth of data exist supporting the notion of “better in, better out”, when it comes to surgery outcomes, but being in a […]

Canine leptospirosis is a climate-sensitive, bacterial, infectious disease of global importance. Despite being vaccine-preventable, leptospirosis is an important cause of morbidity and mortality in dogs. Across North America and the United Kingdom (UK), the prevalence of canine leptospirosis ranges between 4.8-14%, with evidence for increasing prevalence over time. Leptospirosis can be difficult or slow to […]

NorthMiRs is developing nanotechnology-enabled gene therapies for the treatment of sepsis. We have determined microRNAs that are dysregulated in septic patients and packaged them into a stable, synthetic, and scalable lipid nanoparticle delivery vehicle. Our lead therapeutic, NM-001, a miRNA replacement therapy for sepsis-associated cardiomyopathy has been shown to be anti-inflammatory, anti-microbial and protects organs […]

EPAID Technology: EPilepsy AI-Driven Technology aims to automate electrophysiological signal processing practice to assist clinicians in the treatment of epilepsy. We will partner with Springboard, who provides strategically positioned resources to Atlantic Canadian universities and colleges alike, helping them transfer both knowledge and technology into the private sector.

Myelofibrosis is a chronic and life-threatening blood disease. There is a need for accurate risk stratification approaches to guide personalized medicine decisions for these patients. To address this need, we developed a non-invasive blood-based test that is cost-effective, scalable and accurate. Through the Lab2Market program we will explore the market and develop the business case […]